期刊
EXPERT REVIEW OF VACCINES
卷 13, 期 6, 页码 801-815出版社
TAYLOR & FRANCIS LTD
DOI: 10.1586/14760584.2014.897615
关键词
Central Europe; high-risk; immunization; paediatric; recommendations
类别
资金
- GSK
- Apogepha
- Ferring
- Pfizer
- Nestle
- Wyeth Lederle
- sanofi aventis
- Merck Sharp Dohme (MSD)
- Sanofi Pasteur
- MSD
- Novartis
- Baxter
- GSK Slovenia
- PharmaSwiss Slovenia
- Aventis Pasteur
- PharmaSwiss
- Merck
- Wyeth
- Abbott
- GlaxoSmithKline
Over the last decade, childhood immunization has substantially reduced morbidity and mortality from vaccine-preventable diseases. However, particular paediatric risk groups, such as those with comorbidities, may not be adequately vaccinated despite being more susceptible to complications and death from certain infectious diseases. This may be due to lack of immunization recommendations, lack of awareness, or incomplete adherence to existing guidelines. Furthermore, recommendations for immunization can be inconsistent across Europe. An expanded initiative from the Central European Vaccination Awareness Group aims to raise awareness of the different high-risk paediatric groups, differentiate them according to their specific risk, and formalise a guidance statement for the immunization of each population.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据